4th Quarter - Report
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
BIS-2025-0022 - Rare Disease Exemption for Pharmaceutical Tariffs CMS-5545-P - Rare Disease Exemption from GLOBE Model CMS-5546-P - Rare Disease Exemption from GUARD Model
| Lobbyist | Covered position, as disclosed |
|---|---|
| YOKO ROSENBAUM | — |
Pharmacy PHA
HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 Rare Disease Exemption for Most Favored Nation Pricing Proposals
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FRISK | — |
| YOKO ROSENBAUM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.